Further, there is increasing evidence that SARS-CoV-2 enhances susceptibility to hemolytic triggers in G6PD deficient individuals [8–10], and conversely that G6PD deficiency is a predisposing factor for complications from COVID-19 [11, 12]. This evidence concerns the gene G6PD and COVID-19.